Trump's drug czar nominee pushed through a law kneecapping opioid prosecution, DEA officials say

Rep. Tom Marino
(Image credit: Chip Somodevilla/Getty Images)

Last year, Congress passed a law pushed by the pharmaceutical industry that stripped the Drug Enforcement Administration (DEA) of its most potent tool to fight illicit distribution of prescription opioid pain medications to shady clinics and unscrupulous doctors, The Washington Post and CBS's 60 Minutes reported Sunday night. The main sponsors and advocates of the bill were Rep. Tom Marino (R-Pa.) and Rep. Marsha Blackburn (R-Tenn.), whose districts are both hard-hit by the opioid epidemic. Blackburn is running for Senate, for the seat being vacated by Sen. Bob Corker (R), and Marino is President Trump's pick to be America's drug czar. Former President Barack Obama signed the law in April 2016.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.